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Demonstration of autoimmune antibodies to myocardial tissue enables one to detect and assess cardiac disease long after abnormalities in serum enzyme activities are no longer measurable. We describe an indirect immunofluorescence procedure in which cryostat sections of rat heart (ventricle) and Evan's Blue counterstaining are used to detect anti-myocardialantibodies.Sera from patients with myocardial infarct or some other cardiac diseases reveal a distinct fluorescent staining of the sarcolemmal membrane. In contrast, sera from patients with systemic lupus erythematosis demonstrate nuclear plus diffuse staining and sera from myasthen'ta gravis patients show a characteristic striated staining pattern. The role of anti-myocardial antibodies in cardiac disease is discussed briefly. Three hearts from young adult rats were soaked in physiological saline for 1 h and then homogenized in 5 ml of acetone with a glass homogenizer.
The homogenate was then centrifuged (10 000 X g, 10 mm). The supernatant fluid was removed and discarded and the precipitate was washed three times with phosphate-buffered saline and then Figure 1 (A and B) Figure 3 (A and B) , which shows results if counterstaining was not done.
Results
We looked for anti-myocardial antibodies in the sera of 23 patients who had positive titers for anti-DNA antibodies (which is generally diagnostic of systemic lupus erythematosis).
Nine of these samples produced fluorescent patterns when reacted with the rat heart tissue. Reportedly (7), sera from a high percentage of patients with systemic lupus erythematosis contain autoantibodies identical in reactivity to those found in cardiac patients, but with our method the pattern observed is distinctly different from that for sera from cardiac-disease patients.
It includes some diffuse staining of the sarcoplasm, but primarily nuclear staining of the type shown in Figure 4 . None of the samples showed the distinct staining of the sarcolemmal membrane illustrated for sera from cardiac-disease patients.
Sera from myasthenia gravis patients frequently contain autontibothes against muscle tissue. On immunofluorescence analysis, these antibodies are reported (6) to display a striated staining pattern when they are reacted with heart tissue. We confirmed this observation with sera from patients with myasthenia gravis (kindly supplied by Dr. Henry Smith, of our laboratory) by using rat-heart sections ( Figure 5 ). The fluorescent pattern produced by sera from cardiac-disease patients clearly differs from the type of staining shown in Figure 5 .
Samples that contained anti-myocardial antibodies and samples with anti-DNA antibody that reacted with heart tissue were absorbed with either rat heart or liver (50 g/liter).
Myocardial Anti-myocardial antibodies are frequently found in the serum of rheumatic fever patients, especially those with active disease (4, 8, 9 evidence of myocardial injury. They also reported that high titers of anti-myocardial antibodies are often observed in patients with acute myocardial infarction and less frequently in patients with coronary insufficiency without infarction. Thus, assessment of anti-myocardial autoimmunity could be helpful in differential diagnosis of these two diseases.
